Skip to main content
graph.swiss
Alcon N 2.Linie

Alcon N 2.Linie

57.12 CHF-0.10 (-0.17%)
XSWX:ALCEMarket Closed
ListedCHFHealthcareMedical Instruments & Supplies25,000 employees

Company Profile

Legal NameAlcon N 2.Linie
CEOMr. David J. Endicott
HeadquartersChemin de Blandonnet 8
Phone41 589 112 110
Employees (FTE)25,000
SectorHealthcare
IndustryMedical Instruments & Supplies

Business Description

Alcon N 2.Linie is a Swiss pharmaceutical and medical devices company specializing in eye care solutions. The company develops, manufactures, and markets a comprehensive portfolio of products designed to address various ophthalmological conditions and needs. Its offerings include prescription medications for eye diseases, surgical devices for ophthalmic procedures, and over-the-counter eye care products for consumers. Alcon serves multiple market segments including hospitals, surgical centers, ophthalmology clinics, optometry practices, and retail channels. The company operates globally, providing solutions for conditions such as dry eye disease, glaucoma, cataracts, and retinal disorders. As a prominent player in the eye care industry, Alcon plays a significant role in advancing treatment options and improving vision outcomes for patients worldwide. The company combines innovation in pharmaceutical development with advances in surgical technology to address diverse eye health needs across different patient populations and healthcare settings.

Profitability & Growth

Profitability

Profit Margin+7.70%
Operating Margin+12.20%
Return on Equity (TTM)+3.71%
Return on Assets (TTM)+2.54%

Recent Year-End

Revenue8.61B
Revenue / Share21.65
Gross Profit4.83B
EBITDA2.54B
Diluted EPS1.35
Earnings Growth YoY-46.00%
Revenue Growth YoY+9.40%

Balance Sheet Snapshot

Total Cash (MRQ)

1.34B

Total Debt (MRQ)

4.26B

Current Ratio (MRQ)

2.20

Book Value / Share

36.98

Stock Statistics

Shares Outstanding487.7M
Float Shares486.1M
Avg Volume (10d)130.1K
Avg Volume (90d)136.6K

Valuation

Enterprise Value24.40B
Trailing P/E41.16
Price / Book (MRQ)1.50
EV / Revenue2.83
EV / EBITDA13.03

Price Summary

52-Week Low48.16
52-Week High57.92
50-Day MA53.10
200-Day MA53.10
Beta0.70

Dividends

Trailing Div Rate0.35